THE WORK-UP OF ADRENAL INCIDENTALOMA
|
|
|
- Terence French
- 5 years ago
- Views:
Transcription
1 THE WORK-UP OF ADRENAL INCIDENTALOMA Maria Cristina De Martino Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia Università Federico II di Napoli
2 Definition and epidemiology Most experts agree on considering adrenal masses of 10 mm, or more, in size as incidentalomas; asymptomatic; discovered on an imaging study performed for unrelated reason; excluding pts undergoing imaging procedures as part of staging and work-up for cancer. Prevalence in autopsy studies: 2% (range 1-8.7) Increase with age Is similar in and Prevalence in radiological studies: 4% (up to 10-15% in elderly patients) More frequent in than Malignancy is more frequent in pts<20yrs Terzolo M. et al for AME; EJE 2011; Arnaldi G. et al Best Pract Res Clin Endocrinol Metab 2012; Zeiger MA. Et al AACE/AAES Guidelines; Endocr Pract 2009
3 Frequency of the different types of adrenal incidentaloma Arnaldi G. et al Best Pract Res Clin Endocrinol Metab 2012;
4 Frequency of the different types of adrenal incidentaloma Terzolo M. et al for AME; EJE 2011;
5 Frequency of the different types of adrenal incidentaloma Musella M. et al; BMC Surgery 2013;
6 Clinical recommendation based on epidemiology of AIs Considering the possibility of primary adrenal malignancies and metastases from extra-adrenal tumors in all patients with AIs. Excluding adrenal metastases in oncological patients with AIs. Excluding primary adrenal malignancies in all pediatric patients with AIs. Terzolo M. et al for AME; EJE 2011;
7 Radiological assessment (1) Ultrasonography: Potential role in evaluating mass size and growth No role in dd adenomas vs ACC Several limitations Noncontrast CT scan: dd adenomas vs ACC (size <4cm; homogeneous; regular borders; densitometry <10HU) Limitation 10-40% lipid poor adenomas Enhanced CT scan: dd lipid poor adenomas vs ACC (adenomas whash-out >50% after min) Terzolo M. et al for AME; EJE 2011; Arnaldi G. et al Best Pract Res Clin Endocrinol Metab 2012; Zeiger MA. Et al AACE/AAES Guidelines; Endocr Pract 2009
8 1st 2nd
9 lipid poor adenoma metastasis
10 Radiological assessment (2) MRI: dd adenomas vs ACC (chemical shift) Limitations: lipid poor adenomas; costs Scintigraphy (norcholesterol): Dd functioning vs non functioning dd adenomas vs ACC Limitations: high radiation; low specificity PET and particularly PET/CT: dd adenomas vs ACC FNAB : selected patients with a suspicious of adrenal metastasis from non adrenal tumors. Terzolo M. et al for AME; EJE 2011; Arnaldi G. et al Best Pract Res Clin Endocrinol Metab 2012; Zeiger MA. Et al AACE/AAES Guidelines; Endocr Pract 2009
11 Hormonal evaluation Screening of pheo: In all patients with AI Urinary fractioned metanephrines or plasma free methanephrines Terzolo M. et al for AME; EJE 2011; Arnaldi G. et al Best Pract Res Clin Endocrinol Metab 2012; Zeiger MA. Et al AACE/AAES Guidelines; Endocr Pract 2009
12 Hormonal evaluation Screening of pheo: In all patients with AI Urinary fractioned metanephrines or plasma free methanephrines Screening of primary aldosteronism: Patients with AI and hypertension/hypokalemia Aldosterone (ng/dl)/renin ratio (PRA ng/ml) >30-50 Terzolo M. et al for AME; EJE 2011; Arnaldi G. et al Best Pract Res Clin Endocrinol Metab 2012; Zeiger MA. Et al AACE/AAES Guidelines; Endocr Pract 2009
13 Hormonal evaluation Screening of pheo: In all patients with AI Urinary fractioned metanephrines or plasma free methanephrines Screening of primary aldosteronism: Patients with AI and hypertension/hypokalemia Aldosterone (ng/dl)/renin ratio (PRA ng/ml) >30-50 Screening of overt/subclinical CS: In all patients with AI DST 1 mg or more? Which cut-off? -> Prof Mannelli Terzolo M. et al for AME; EJE 2011; Arnaldi G. et al Best Pract Res Clin Endocrinol Metab 2012; Zeiger MA. Et al AACE/AAES Guidelines; Endocr Pract 2009
14 Hormonal evaluation Screening of pheo: In all patients with AI Urinary fractioned metanephrines or plasma free methanephrines Screening of primary aldosteronism: Patients with AI and hypertension/hypokalemia Aldosterone (ng/dl)/renin ratio (PRA ng/ml) >30-50 Screening of overt/subclinical CS: In all patients with AI DST 1 mg or more? Which cut-off? Hyperandrogenism?
15 Follow-up Arnaldi G. et al Best Pract Res Clin Endocrinol Metab 2012
16 Screening for complication In which patients? How often? How?
17 Grazie
18
19 Subclinical hypercortisolism is associated with the risk of incident CVEs. a long-term biochemical follow-up is also required because of the risk of subclinical hypercortisolism development.
20
The Management of adrenal incidentaloma
The Management of adrenal incidentaloma Dimitrios Linos, MD Director of Surgery, Hygeia Hospital, Athens, Greece Consultant in Surgery, Massachusetts General Hospital, Boston, USA 8 th Postgraduate Course
Dimitrios Linos, M.D., Ph.D. Professor of Surgery National & Kapodistrian University of Athens
Dimitrios Linos, M.D., Ph.D. Professor of Surgery National & Kapodistrian University of Athens What is an adrenal incidentaloma? An adrenal incidentaloma is defined as an adrenal tumor initially diagnosed
ADRENAL INCIDENTALOMA. Jamii St. Julien
ADRENAL INCIDENTALOMA Jamii St. Julien Outline Definition Differential Evaluation Treatment Follow up Questions Case Definition The phenomenon of detecting an otherwise unsuspected adrenal mass on radiologic
Endocrine MR. Jan 30, 2015 Michael LaFata, MD
Endocrine MR Jan 30, 2015 Michael LaFata, MD Brief case 55-year-old female in ED PMH: HTN, DM2, HLD, GERD CC: Epigastric/LUQ abdominal pain, N/V x2 days AF, HR 103, BP 155/85, room air CMP: Na 133, K 3.6,
Adrenal incidentaloma guideline for Northern Endocrine Network
Adrenal incidentaloma guideline for Northern Endocrine Network Definition of adrenal incidentaloma Adrenal mass detected on an imaging study done for indications that are not related to an adrenal problem
Inquadramento Clinico dell IncIdentaloma SurrenalIco
Ferrara, 7 dicembre 2012 Inquadramento Clinico dell IncIdentaloma SurrenalIco Marta Bondanelli Sezione di Endocrinologia Dip. di Scienze Mediche Università degli Studi di Ferrara ADRENAL INCIDENTALOMA
Nephtali R. Gomez, M.D. To The Incidental Adrenal Mass
Nephtali R. Gomez, M.D. To The Incidental Adrenal Mass The Complete Idiot s Guide to The Incidental Adrenal Mass Defini:on Any adrenal mass 1cm or more in diameter discovered on a radiologic exam performed
Adrenal Incidentalomas. Dr A Tabarin University Hospital of Bordeaux (France)
Adrenal Incidentalomas Dr A Tabarin University Hospital of Bordeaux (France) Adrenal Incidentalomas - Basics Definition : Incidental Discovery Rate of discovery # 4 % over 50 yo Bilateral AI : 10-15 %
Evaluation of Thyroid Nodules
Evaluation of Thyroid Nodules Stephan Kowalyk, MD January 25 28, 2018 1 Primary goal Exclude malignancy Incidental thyroid nodules If found on CT, MRI, PET scan, carotid Doppler ULTRASOUND!! January 25
A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion
Original Article Endocrinol Metab 2015;30:481-487 http://dx.doi.org/10.3803/enm.2015.30.4.481 pissn 2093-596X eissn 2093-5978 A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas:
MILD HYPERCORTISOLISM DUE TO ADRENAL ADENOMA: IS IT REALLY SUBCLINICAL?
MILD HYPERCORTISOLISM DUE TO ADRENAL ADENOMA: IS IT REALLY SUBCLINICAL? Alice C. Levine, MD Professor of Medicine Division of Endocrinology, Diabetes and Bone Diseases Georgia-AACE 2017 Annual Meeting
Incidental adrenal masses A primary care approach
CLINICAL Incidental adrenal masses A primary care approach Rasha Gendy, Prem Rashid Background The common use of cross-sectional imaging for the investigation of abdominal and thoracic illness has resulted
William F. Young, Jr., MD, MSc Professor of Medicine, Mayo Clinic, Rochester, MN USA
The Year in Adrenal William F. Young, Jr., MD, MSc Professor of Medicine, Mayo Clinic, Rochester, MN USA Division of ENDOCRINOLOGY, DIABETES, METABOLISM & NUTRITION 2018 Mayo Foundation for Medical Education
Radiology reporting of adrenal incidentalomas who requires further testing?
CLINICAL PRACTICE Clinical Medicine 2014 Vol 14, No 1: 16 21 Radiology reporting of adrenal incidentalomas who requires further testing? Authors: Fiona Paterson, A Aikaterini Theodoraki, B Adaugo Amajuoyi,
Adrenal Incidentaloma
REVIEW ARTICLE Adrenal Incidentaloma Fenny Elvina Ridho, Fabiola MS Adam, John M.F.Adam Diabetes and Lipid Center, Department of Internal Medicine, Faculty of Medicine, University of Hasanuddin. Jl. Perintis
Case Based Urology Learning Program
Case Based Urology Learning Program Resident s Corner: UROLOGY Case Number 4 CBULP 2010 004 Case Based Urology Learning Program Editor: Associate Editors: Manager: Case Contributors: Steven C. Campbell,
STANDARDIZED MANAGEMENT RECOMMENDATIONS FOR ADRENAL NODULES: EVIDENCE-BASED CONSENSUS POWERSCRIBE MACROS FROM AN ACADEMIC/PRIVATE PRACTICE
STANDARDIZED MANAGEMENT RECOMMENDATIONS FOR ADRENAL NODULES: EVIDENCE-BASED CONSENSUS POWERSCRIBE MACROS FROM AN ACADEMIC/PRIVATE PRACTICE COLLABORATIVE Pamela Johnson 1, Darcy Wolfman 2, Upma Rawal 3,
Adrenal Incidentaloma Management
Adrenal Incidentaloma Management Full Title of Guideline: Author Management of Incidentally-discovered Adrenal Lesions ( Incidentalomas ) Mr David Chadwick Consultant Endocrine Surgeon david.chadwick2@nuh.nhs.uk
Approach to Adrenal Incidentaloma. Alice Y.Y. Cheng, MD, FRCP
Approach to Adrenal Incidentaloma Alice Y.Y. Cheng, MD, FRCP Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form
Preoperative workup in the assessment of adrenal incidentalomas: outcome from 282 consecutive laparoscopic adrenalectomies
Musella et al. BMC Surgery 2013, 13:57 RESEARCH ARTICLE Open Access Preoperative workup in the assessment of adrenal incidentalomas: outcome from 282 consecutive laparoscopic adrenalectomies Mario Musella
18F-FDG PET for the Identification of Adrenocortical Carcinomas among Indeterminate Adrenal Tumors at Computed Tomography Scanning
World J Surg (2010) 34:1506 1510 DOI 10.1007/s00268-010-0576-3 18F-FDG PET for the Identification of Adrenocortical Carcinomas among Indeterminate Adrenal Tumors at Computed Tomography Scanning Marie Laure
The Work-up and Treatment of Adrenal Nodules
The Work-up and Treatment of Adrenal Nodules Lawrence Andrew Drew Shirley, MD, MS, FACS Assistant Professor of Surgical-Clinical Department of Surgery Division of Surgical Oncology The Ohio State University
Il Carcinoma Surrenalico
Il Carcinoma Surrenalico Massimo Terzolo Medicina Interna I AOU San Luigi Orbassano (TO) Italy AGENDA DIAGNOSIS CLINICAL PRESENTATION IMPACT ON PROGNOSIS TREATMENT DIAGNOSIS 23-yr-old lady October 2010,
ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain
ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain OUR APPROACH Incidental adrenal nodule/mass Isaac R Francis, M.B;B.S University of Michigan, Ann Arbor, Michigan Disclosures None (in memory) M Korobkin,
AME Position Statement on Adrenal Incidentaloma.
This is an author version of the contribution published on: Questa è la versione dell autore dell opera: AME Position Statement on Adrenal Incidentaloma. Vol. 164 doi: 10.1530/EJE-10-1147 The definitive
Trust Guideline for the Investigation of Incidental Adrenal Masses in Adults
A clinical guideline recommended for use For Use in: A&E, Medical Assessment Unit, ITU/HDU Medical and Surgical wards By: Medical, Clinical investigation unit and Surgical staff For: Investigation of incidental
I farmaci ad azione surrenalica: METIRAPONE ed OSILODROSTAT
I farmaci ad azione surrenalica: METIRAPONE ed OSILODROSTAT Maria Cristina De Martino Dipartimento di Medicina Clinica e Chirurgia Sezione di Endocrinologia, Università Federico II di Napoli, Italy 1 Treatment
The Evaluation of the Incidental Adrenal Mass and Not-So-Incidental Adrenal Hormone Excess
The Evaluation of the Incidental Adrenal Mass and Not-So-Incidental Adrenal Hormone Excess Richard J. Auchus, MD, PhD, FACE Depts. Internal Medicine/MEND & Pharmacology Endocrinology Fellowship Program
Review Article Incidental Adrenal Nodules and Masses: The Imaging Approach
International Endocrinology Volume 2015, Article ID 410185, 6 pages http://dx.doi.org/10.1155/2015/410185 Review Article Incidental Adrenal Nodules and Masses: The Imaging Approach J. Willatt, 1,2 S. Chong,
Mineralocorticoids: aldosterone Angiotensin II/renin regulation by sympathetic tone; High potassium will stimulate and ACTH Increase in aldosterone
Disease of the Adrenals 1 Zona Glomerulosa Mineralocorticoids: aldosterone Angiotensin II/renin regulation by sympathetic tone; High potassium will stimulate and ACTH Increase in aldosterone leads to salt
Adrenal gland Incidentaloma
Adrenal gland Incidentaloma Topic review 17 sep 2008 Anatomy 1 Anatomical consideration Blood supply Artery: small branches from Inf. phrenic, renal artery and aorta Vein: Rt : medial aspect to IVC Lt
Endocrine Surgery When to Refer and What We Do
Endocrine Surgery When to Refer and What We Do None Disclosures W. Heath Giles, M.D., F.A.C.S. Surgery Residency Program Director Assistant Professor of Surgery What is Endocrine Surgery? Who performs
ADRENAL LESIONS 10/09/2012. Adrenal + lesion. Introduction. Common causes. Anatomy. Financial disclosure. Dr. Boraiah Sreeharsha. Nothing to declare
ADRENAL LESIONS Financial disclosure Nothing to declare Dr. Boraiah Sreeharsha MBBS;FRCR;FRCPSC Introduction Adrenal + lesion Adrenal lesions are common 9% of the population Increase in the detection rate
Maria Chiara Zatelli Sezione di Endocrinologia e Medicina Interna Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università
Maria Chiara Zatelli Sezione di Endocrinologia e Medicina Interna Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università degli Studi di Ferrara Molecular markers? Endocrinology
Nuclear medicine in endocrinology
Nuclear medicine in endocrinology Thyroid gland: anatomy, function, inflammation, Nuclear medicine in endocrinology tumor dignitiy Parathyroid gland: localisation Adrenal cortex: function Adrenal medulla:
57-year-old man with anxiety, diaphoresis, fatigue and bilateral adrenal nodules. Celeste Thomas November 1, 2012
57-year-old man with anxiety, diaphoresis, fatigue and bilateral adrenal nodules Celeste Thomas November 1, 2012 History of Present Illness 8 months prior to presentation developed intermittent right flank
Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care
Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:
Long-term follow-up of patients with benign thyroid nodules
Riyadh - January 31, 2017 Long-term follow-up of patients with benign thyroid nodules Cosimo Durante Department of Internal Medicine and Medical Specialties Sapienza University of Rome cosimo.durante@uniroma1.it
Endocrine. Endocrine as it relates to the kidney. Sarah Elfering, MD University of Minnesota
Endocrine Sarah Elfering, MD University of Minnesota Endocrine as it relates to the kidney Parathyroid gland Vitamin D Endocrine causes of HTN Adrenal adenoma PTH Bone Kidney Intestine 1, 25 OH Vitamin
ADRENAL INCIDENTALOMAS _ A MANAGEMENT APPROACH Dr Tan Khai Tong
T H E M E : A S T H M A ARENAL INCIENTALOMAS _ A MANAGEMENT APPROACH r Tan Khai Tong SUMMARY The adrenal incidentaloma is an increasingly common clinical problem. Although most of these masses are innocuous,
Current Management of Adrenal Cortical Carcinoma
Current Management of Adrenal Cortical Carcinoma American Association of Clinical Endocrinologists Texas Chapter of the AACE Annual Meeting And Texas Endocrine Surgery Symposium August 4, 2017 Jeffrey
Incidental Adrenal Nodules Differential Diagnosis
Adrenal Stuff Richard J. Auchus, MD, PhD, FACE Division of Metabolism, Endocrinology & Diabetes Departments of Internal Medicine & Pharmacology University of Michigan/VA Ann Arbor Incidental Adrenal Nodules
Endocrine Testing. Alice Y.Y. Cheng, MD, FRCP October 14, 2015
Endocrine Testing Alice Y.Y. Cheng, MD, FRCP October 14, 2015 Disclosure No disclosures relevant to the content of this workshop Learning Objectives By the end of this workshop, you will be able to: 1.
Chiara Simeoli. Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia Università Federico II di Napoli
Chiara Simeoli Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia Università Federico II di Napoli GC REPLACEMENT TREATMENT AN IDEAL DRUG SHOULD: normalize the standardized mortality
Clinical Characteristics for 348 Patients with Adrenal Incidentaloma
Original Article Endocrinol Metab 2013;28:20-25 http://dx.doi.org/10.3803/enm.2013.28.1.20 pissn 2093-596X eissn 2093-5978 Clinical Characteristics for 348 Patients with Adrenal Incidentaloma Jongho Kim,
8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy.
U. Joseph Schoepf, MD Prof. (h.c.), FAHA, FSCBT-MR, FNASCI, FSCCT Professor of Radiology, Medicine, and Pediatrics Director, Division of Cardiovascular Imaging Consultant for / research support from: Astellas
11/1/2014. Radiologic incidentalomas Ordering pitfalls Newer technology and applications
Bilal Tahir, MD Gitasree Borthakur, MD Indiana University School of Medicine Department of Radiology & Imaging Sciences October 31, 2014 ACP 2014 Dr. V. Aaron Nuclear (vaaron@iupui.edu) Dr. S. Westphal
Pheochromocytoma AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY ILLINOIS CHAPTER OCTOBER 13, 2018
Pheochromocytoma AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY ILLINOIS CHAPTER OCTOBER 13, 2018 Steven A. De Jong, M.D., FACS, FACE Professor and Vice Chair of Surgery Chief, Division of General Surgery
Management of adrenal incidentalomas
31 Management of adrenal incidentalomas KEVIN MURTAGH, NANA MUHAMMAD AND MAREK MILLER The return of a scan result with reference to an incidental finding of an adrenal mass is a common scenario. 1 The
Adrenal incidentaloma
Adrenal incidentaloma Prevalence 5% post-mortem series 4% CT series 6-20% CT series in patients with Hx extra-adrenal malignancy Commoner with increasing age Associated with adrenal hyperfunction in 15%
Thyroid nodules. Most thyroid nodules are benign
Thyroid nodules Postgraduate Course in General Surgery Jessica E. Gosnell MD Assistant Professor March 22, 2011 Most thyroid nodules are benign thyroid nodules occur in 77% of the world s population palpable
Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study
Yeomans et al. BMC Endocrine Disorders (2015) 15:6 DOI 10.1186/s12902-015-0001-x RESEARCH ARTICLE Open Access Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a
Management of adrenal incidentaloma: the role of adrenalectomy may be underestimated
Ye et al. BMC Surgery (2016) 16:41 DOI 10.1186/s12893-016-0154-1 RESEARCH ARTICLE Open Access Management of adrenal incidentaloma: the role of adrenalectomy may be underestimated Yun-lin Ye 1, Xiao-xu
Evaluating and managing adrenal incidentalomas
REVIEW CME CREDIT THOTTATHIL GOPAN, MD Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic ERICK REMER, MD Department of Radiology, Cleveland Clinic AMIR H. HAMRAHIAN, MD Department
Year 2004 Paper two: Questions supplied by Megan 1
Year 2004 Paper two: Questions supplied by Megan 1 QUESTION 96 A 32yo woman if found to have high blood pressure (180/105mmHg) at an insurance medical examination. She is asymptomatic. Clinical examination
Update in Pheochromocytoma/Paraganglioma: Focus on Diagnosis and Management
Update in Pheochromocytoma/Paraganglioma: Focus on Diagnosis and Management Ohk-Hyun Ryu, MD. Associate Professor, Department of Internal Medicine Division of Endocrinology and Metabolism College of Medicine,
SA CME Information SA CME INFORMATION. Target Audience
SA CME INFORMATION SA CME Information Description Adrenal Imaging: A Three-category Approach To Managing The Adrenal "Incidentaloma" Imaging plays a critical role in the work-up and clinical management
Subclinical Cushing s Syndrome
Subclinical Cushing s Syndrome AACE 26th Annual Scientific & Clinical Congress Associate Clinical Professor of Medicine and Clinical Chief University of Miami Miller Scholl of Medicine Miami, Florida aayala2@miami.edu
Pheochromocytoma: updates on management strategies
Pheochromocytoma: updates on management strategies Hanaa Tarek El-Zawawy Lecturer of Internal Medicine and Endocrinology Alexandria University Contents: Introduction Clinical presentation Investigations
Adrenal Mass. Cynthia Kwong SUNY Downstate Medical Center Grand Rounds October 13, 2016
Adrenal Mass Cynthia Kwong SUNY Downstate Medical Center Grand Rounds October 13, 2016 Case Presentation 65F found to have a 4cm left adrenal mass in 2012 now presents with 6.7cm left adrenal mass PMHx:
Thyroid nodules 3/22/2011. Most thyroid nodules are benign. Thyroid nodules: differential diagnosis
Most thyroid nodules are benign Thyroid nodules Postgraduate Course in General Surgery thyroid nodules occur in 77% of the world s population palpable thyroid nodules occur in about 5% of women and 1%
FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave
FDG PET/CT STAGING OF LUNG CANCER Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER FDG PET/CT is used in all patients with lung cancer who are considered for curative treatment to exclude occult disease.
Pituitary, adrenal and thyroid incidentalomas
Pituitary, adrenal and thyroid incidentalomas Endocrine-Related Cancer (1998) 5 131-150 H E Turner, N R Moore 1, J V Byrne 1 and J A H Wass Departments of Endocrinology and 1 Radiology, Radcliffe Infirmary
Value of true whole-body FDG- PET/CT scanning protocol in oncology and optimization of its use based on primary malignancy
Value of true whole-body FDG- PET/CT scanning protocol in oncology and optimization of its use based on primary malignancy Ronnie Sebro MD, Ph.D Carina Mari Aparici MD, Miguel Hernandez Pampaloni MD, PhD
Clinical characteristics and follow-up of incidentally found adrenal tumours - results from a single tertiary centre
Cent. Eur. J. Med. 9(2) 2014 292-301 DOI: 10.2478/s11536-013-0199-9 Central European Journal of Medicine Clinical characteristics and follow-up of incidentally found adrenal tumours - results from a single
Adrenal Incidentaloma Sara Galac, DVM PhD Faculty of Veterinary Medicine, Utrecht University, The Netherlands
Adrenal Incidentaloma Sara Galac, DVM PhD Faculty of Veterinary Medicine, Utrecht University, The Netherlands In the last decennium, the diagnosis of adrenal incidentaloma (AI) has become increasingly
COPYRIGHTED MATERIAL. Adrenal Imaging. 1.1 Introduction. Khaled M. Elsayes 1, Isaac R. Francis 1, Melvyn Korobkin 1 and Gerard M.
1 Adrenal Imaging Khaled M. Elsayes 1, Isaac R. Francis 1, Melvyn Korobkin 1 and Gerard M. Doherty 2 1 Department of Radiology, University of Michigan 2 Department of Radiology and Surgery, University
Pituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs
Pituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs Shereen Ezzat, MD, FRCP(C), FACP Professor Of Medicine & Oncology Head, Endocrine Oncology Princess Margaret Hospital/University
AVS and IPSS: The Basics and the Pearls William F. Young, Jr., MD, MSc Professor of Medicine Mayo Clinic College of Medicine Rochester, MN, USA
AVS and IPSS: The Basics and the Pearls William F. Young, Jr., MD, MSc Professor of Medicine Mayo Clinic College of Medicine Rochester, MN, USA 2016 Mayo Foundation for Medical Education and Research.
PET/CT in lung cancer
PET/CT in lung cancer Andrei Šamarin North Estonia Medical Centre 3 rd Baltic Congress of Radiology 08.10.2010 Imaging in lung cancer Why do we need PET/CT? CT is routine imaging modality for staging of
REVIEW. Distinguishing benign from malignant adrenal masses
Cancer Imaging (2003) 3, 102 110 DOI: 10.1102/1470-7330.2003.0006 CI REVIEW Distinguishing benign from malignant adrenal masses Isaac R Francis Professor of Radiology, Department of Radiology, University
Case Rep Oncol 2010;3: DOI: /
416 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the
5/18/2013. Most thyroid nodules are benign. Thyroid nodules: new techniques in evaluation
Most thyroid nodules are benign Thyroid nodules: new techniques in evaluation Incidence Etiology Risk factors Diagnosis Gene classification system Treatment Postgraduate Course in General Surgery Jessica
Management of Thyroid Nodules. February 2 nd, 2018 Sarah Hopkins
Management of Thyroid Nodules February 2 nd, 2018 Sarah Hopkins No disclosures Goals: Review Initial Evaluation of Thyroid Nodules Review Indications for Biopsy Approach to Multinodular Goiter Review Management
A Rare Case of Subclinical Primary Aldosteronism and Subclinical Cushing s Syndrome without Cardiovascular Complications
Tokai J Exp Clin Med., Vol. 41, No. 1, pp. 35-41, 216 A Rare Case of Subclinical Primary Aldosteronism and Subclinical Cushing s Syndrome without Cardiovascular Complications Natsumi KITAJIMA *1, Toshiro
Chirurgie beim oligo-metastatischen NSCLC
24. Ärzte-Fortbildungskurs in Klinischer Onkologie 20.-22. Februar 2014, Kantonsspital St. Gallen Chirurgie beim oligo-metastatischen NSCLC Prof. Dr. med. Walter Weder Klinikdirektor Thoraxchirurgie, UniversitätsSpital
Firenze, 21/07/2017. Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia Università Federico II Naples, Italy
Firenze, 21/07/2017 Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia Università Federico II Naples, Italy Efficacia e tollerabilità del trattamento con idrocortisone a doppio rilascio
Evaluation of Incidental Lesions Discovered at Imaging
Evaluation of Incidental Lesions Discovered at Imaging Radiology Associates of Indianapolis Richard L Scales MD Indeterminate Lesions Current Discussion Future Discussion Thyroid nodule Adrenal nodule
Conferencia III: Dilemas en el tratamiento de Feocromocitomas y Paragangliomas. Dilemmas in Management of Pheochromocytoma and Paraganglioma
Conferencia III: Dilemas en el tratamiento de Feocromocitomas y Paragangliomas Dilemmas in Management of Pheochromocytoma and Paraganglioma William F. Young, Jr., MD, MSc Mayo Clinic Rochester, MN, USA
Diagnostic et prise en charge des phéochromocytomes (PH) et paragangliomes (PG)
Diagnostic et prise en charge des phéochromocytomes (PH) et paragangliomes (PG) PF Plouin, L Amar et AP Gimenez-Roqueplo COMETE, ENS@T et HEGP/Université Paris-Descartes Chromaffin tumors: PH and PG PH
SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, :00 12:10 p.m.
SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, 2018 10:00 12:10 p.m. Staging Susan E. Sharp, MD 1. In the International Neuroblastoma Risk Group Staging
Incidental adrenal pheochromocytoma a report on three cases
Incidental adrenal pheochromocytoma a report on three cases Incidental adrenal pheochromocytoma a report on three cases M S A Cooray 1, Uditha Bulugahapitiya 2, I S H Liyanage 3, Anuruddha M Abeygunasekera
Evaluation and Management of Thyroid Nodules. Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada
Evaluation and Management of Thyroid Nodules Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada Disclosure Consulting Amgen Speaking Amgen Objectives Understand the significance of incidental
Multi-Organ Distant Metastases in Follicular Thyroid Cancer- Rare Case Report
Multi-Organ Distant Metastases in Follicular Thyroid Cancer- Rare Case Report Dr. Mohammed Raza 1, Dr. Sindhuri K 2, Dr. Dinesh Reddy Y 3 1 Professor, Department of Surgery, JSS University, Mysore, India
Patient-specific Management of Adrenal Incidentalomas using Predictive and Prescriptive Analytics
University of Technology Eindhoven Master s Thesis (1BM96) Master Operations Management & Logistics Patient-specific Management of Adrenal Incidentalomas using Predictive and Prescriptive Analytics Job
Carcinoma midollare tiroideo familiare
12 AME Italian Meeting 6 Joint Meeting with AACE Carcinoma midollare tiroideo familiare Profilo genetico e stratificazione del rischio Maria Chiara Zatelli Sezione di Endocrinologia Dipartimento di Scienze
Pheochromocytomas (PHEOs) are rare catecholamineproducing
Usefulness of Standardized Uptake Values for Distinguishing Adrenal Glands with Pheochromocytoma from Normal Adrenal Glands by Use of 6- F-Fluorodopamine PET Henri J.L.M. Timmers 1,2, Jorge A. Carrasquillo
Pituitary Tumors and Incidentalomas. Bijan Ahrari, MD, FACE, ECNU Palm Medical Group
Pituitary Tumors and Incidentalomas Bijan Ahrari, MD, FACE, ECNU Palm Medical Group Background Pituitary incidentaloma: a previously unsuspected pituitary lesion that is discovered on an imaging study
Short summary of published results of PET with fluoromethylcholine (18F) in prostate cancer
Short summary of published results of PET with fluoromethylcholine (18F) in prostate cancer JN TALBOT and all the team of Service de Médecine Nucléaire Hôpital Tenon et Université Pierre et Marie Curie,
IAEA RTC. PET/CT and Planning of Radiation Therapy 20/08/2014. Sarajevo (Bosnia & Hercegovina) Tuesday, June :40-12:20 a.
IAEA RTC PET/CT and Planning of Radiation Therapy Sarajevo (Bosnia & Hercegovina) Tuesday, June 17 2014 11:40-12:20 a.m María José García Velloso Servicio de Medicina Nuclear Clínica Universidad de Navarra
Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
PET/CT in breast cancer staging
PET/CT in breast cancer staging Anni Morsing Consultant, PhD, DMSc Rigshospitalet 1 18F- FDG PET/CT for breastcancer staging Where is the clinical impact? To which women should 18F- FDG PET/CT be offered?
APPROCCIO DIAGNOSTICO-TERAPEUTICO TERAPEUTICO AL CARCINOMA DIFFERENZIATO DELLA TIROIDE Sabato 6 aprile 2013 Aula Magna Nuovo Arcispedale S.
dal 1846 APPROCCIO DIAGNOSTICO-TERAPEUTICO TERAPEUTICO AL CARCINOMA DIFFERENZIATO DELLA TIROIDE Sabato 6 aprile 2013 Aula Magna Nuovo Arcispedale S. Anna Ruolo dell analisi genetica Maria Chiara Zatelli
A Woman with Long-Standing Hypertension Diagnosed with Metastatic Adrenal Carcinoma
A Woman with Long-Standing Hypertension Diagnosed with Metastatic Adrenal Carcinoma Mir A. Alikhan, MD* Frank J. Pikul, MD Peter P. Toth, MD, PhD *Department of Hematology/Oncology, Sterling Rock Falls
Daniela Faivovich K., MS VII Universidad de Chile Gillian Lieberman, MD Harvard Medical School
Daniela Faivovich K., MS VII Universidad de Chile Gillian Lieberman, MD Harvard Medical School May 21st, 2010 56 year old male patient History of hypertension, hyperlipidemia and insulin-resistance 2009:
A case of micturition syncope
A case of micturition syncope Kimberly Bundick, PA-S S L I D E 1 Agenda Purpose Utilize case to illustrate classic finding of an interesting pathology Agenda Case study Epidemiology, etiology of disease
Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased
Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased analysis Roel Schlijper Fellow Radiation Oncology BC Cancer, Prince George Disclosures No conflicts
ORIGINAL ARTICLE. Introduction
doi: 10.2169/internalmedicine.0550-17 Intern Med Advance Publication http://internmed.jp ORIGINAL ARTICLE Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with
301 S. Westfield Rd., Suite 250 Madison, WI See inside for information about our Endocrine Surgery Referral Program
301 S. Westfield Rd., Suite 250 Madison, WI 53717 See inside for information about our Endocrine Surgery Referral Program December 2017 Dear Colleague, Thank you for referring your patient(s) to UW Health